136 related articles for article (PubMed ID: 9216828)
21. Pure antiestrogens and breast cancer.
Elkak AE; Mokbel K
Curr Med Res Opin; 2001; 17(4):282-9. PubMed ID: 11922402
[TBL] [Abstract][Full Text] [Related]
22. Homologs of idoxifene: variation of estrogen receptor binding and calmodulin antagonism with chain length.
Hardcastle IR; Rowlands MG; Grimshaw RM; Houghton J; Jarman M
J Med Chem; 1996 Feb; 39(4):999-1004. PubMed ID: 8632423
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulators.
Grese TA; Pennington LD; Sluka JP; Adrian MD; Cole HW; Fuson TR; Magee DE; Phillips DL; Rowley ER; Shetler PK; Short LL; Venugopalan M; Yang NN; Sato M; Glasebrook AL; Bryant HU
J Med Chem; 1998 Apr; 41(8):1272-83. PubMed ID: 9548817
[TBL] [Abstract][Full Text] [Related]
24. Effect of twenty-four-week treatment with the antiestrogen EM-800 on estrogen-sensitive parameters in intact and ovariectomized mice.
Luo S; Sourla A; Labrie C; Gauthier S; Merand Y; Belanger A; Labrie F
Endocrinology; 1998 May; 139(5):2645-56. PubMed ID: 9564882
[TBL] [Abstract][Full Text] [Related]
25. Structure activity relationship of some 2,3-diaryl-2H-1-benzopyrans to their anti-implantation, estrogenic and antiestrogenic activities in rat.
Dhar JD; Dwivedi A; Srivastava A; Setty BS
Contraception; 1994 Jun; 49(6):609-16. PubMed ID: 8070266
[TBL] [Abstract][Full Text] [Related]
26. EM-800, a novel antiestrogen, acts as a pure antagonist of the transcriptional functions of estrogen receptors alpha and beta.
Tremblay A; Tremblay GB; Labrie C; Labrie F; Giguère V
Endocrinology; 1998 Jan; 139(1):111-8. PubMed ID: 9421405
[TBL] [Abstract][Full Text] [Related]
27. The effects of antioestrogens on the oestrogen receptor.
Ruh TS; Baudendistel LJ; Nicholson WF; Ruh MF
J Steroid Biochem; 1979 Jul; 11(1A):315-22. PubMed ID: 491601
[No Abstract] [Full Text] [Related]
28. Morphological changes induced by 6-month treatment of intact and ovariectomized mice with tamoxifen and the pure antiestrogen EM-800.
Sourla A; Luo S; Labrie C; Bélanger A; Labrie F
Endocrinology; 1997 Dec; 138(12):5605-17. PubMed ID: 9389549
[TBL] [Abstract][Full Text] [Related]
29. Diethylstilbestrol metabolites and analogs. New probes for the study of hormone action.
Korach KS; Metzler M; McLachlan JA
J Biol Chem; 1979 Sep; 254(18):8963-8. PubMed ID: 479173
[No Abstract] [Full Text] [Related]
30. Diethylstilbestrol metabolites and analogs. Stereochemical probes for the estrogen receptor binding site.
Korach KS; Chae K; Levy LA; Duax WL; Sarver PJ
J Biol Chem; 1989 Apr; 264(10):5642-7. PubMed ID: 2925625
[TBL] [Abstract][Full Text] [Related]
31. Effect of dehydroepiandrosterone and the antiestrogen EM-800 on growth of human ZR-75-1 breast cancer xenografts.
Couillard S; Labrie C; Bélanger A; Candas B; Pouliot F; Labrie F
J Natl Cancer Inst; 1998 May; 90(10):772-8. PubMed ID: 9605648
[TBL] [Abstract][Full Text] [Related]
32. Diethylstilbestrol binding to estrogen receptor in mammary tissue and uteri of C3H/HeJ mice.
Okey AB; Bondy GP
J Natl Cancer Inst; 1978 Sep; 61(3):719-24. PubMed ID: 278849
[No Abstract] [Full Text] [Related]
33. Synthesis of 3-phenyl-4-phenylvinyl benzopyranones and the corresponding 2,2-dimethyl-benzopyrans with structural similarity to estradiol, as estrogen receptor ligands.
Gupta A; Raghunandan R; Kumar A; Maulik PR; Dwivedyc A; Keshri G; Singh MM; Ray S
Med Chem; 2007 Sep; 3(5):446-54. PubMed ID: 17897069
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of estrogen binding in uterine cytosol during the perinatal period in the rat.
Kimmel GL; Harmon JR
J Steroid Biochem; 1980 Jan; 12():73-5. PubMed ID: 7421239
[No Abstract] [Full Text] [Related]
35. Long-term inhibitory effects of a novel anti-estrogen on the growth of ZR-75-1 and MCF-7 human breast cancer tumors in nude mice.
Luo S; Martel C; Gauthier S; Mérand Y; Bélanger A; Labrie C; Labrie F
Int J Cancer; 1997 Nov; 73(5):735-9. PubMed ID: 9398055
[TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene.
Grese TA; Cho S; Finley DR; Godfrey AG; Jones CD; Lugar CW; Martin MJ; Matsumoto K; Pennington LD; Winter MA; Adrian MD; Cole HW; Magee DE; Phillips DL; Rowley ER; Short LL; Glasebrook AL; Bryant HU
J Med Chem; 1997 Jan; 40(2):146-67. PubMed ID: 9003514
[TBL] [Abstract][Full Text] [Related]
37. Antagonism of estrogen action with a new benzothiophene derived antiestrogen.
Black LJ; Jones CD; Falcone JF
Life Sci; 1983 Feb; 32(9):1031-6. PubMed ID: 6827921
[TBL] [Abstract][Full Text] [Related]
38. Specific stereochemistry of OP-1074 disrupts estrogen receptor alpha helix 12 and confers pure antiestrogenic activity.
Fanning SW; Hodges-Gallagher L; Myles DC; Sun R; Fowler CE; Plant IN; Green BD; Harmon CL; Greene GL; Kushner PJ
Nat Commun; 2018 Jun; 9(1):2368. PubMed ID: 29915250
[TBL] [Abstract][Full Text] [Related]
39. Competitive binding assay for estrogen receptor in monolayer culture: measure of receptor activation potency.
Stoessel S; Leclercq G
J Steroid Biochem; 1986 Nov; 25(5A):677-82. PubMed ID: 2432356
[TBL] [Abstract][Full Text] [Related]
40. LY353381.HCl: a novel raloxifene analog with improved SERM potency and efficacy in vivo.
Sato M; Turner CH; Wang T; Adrian MD; Rowley E; Bryant HU
J Pharmacol Exp Ther; 1998 Oct; 287(1):1-7. PubMed ID: 9765314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
